ZA96122B - A pharmaceutical formulation - Google Patents

A pharmaceutical formulation

Info

Publication number
ZA96122B
ZA96122B ZA96122A ZA96122A ZA96122B ZA 96122 B ZA96122 B ZA 96122B ZA 96122 A ZA96122 A ZA 96122A ZA 96122 A ZA96122 A ZA 96122A ZA 96122 B ZA96122 B ZA 96122B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Application number
ZA96122A
Inventor
Thorkild Christensen
Per Balschmidt
Hans Holmegaard Soerensen
Ole Hvilsted
Lars Thim
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of ZA96122B publication Critical patent/ZA96122B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/27Growth hormone [GH] (Somatotropin)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/26Glucagons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05Dipeptides
ZA96122A 1995-01-13 1996-01-09 A pharmaceutical formulation ZA96122B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37252495A 1995-01-13 1995-01-13

Publications (1)

Publication Number Publication Date
ZA96122B true ZA96122B (en) 1996-07-24

Family

ID=23468502

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA96122A ZA96122B (en) 1995-01-13 1996-01-09 A pharmaceutical formulation

Country Status (7)

Country Link
EP (1) EP0804224A1 (en)
JP (1) JPH10511963A (en)
KR (1) KR19980701350A (en)
AU (1) AU4329496A (en)
IL (1) IL116741A0 (en)
WO (1) WO1996021459A1 (en)
ZA (1) ZA96122B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100236393B1 (en) * 1996-02-02 1999-12-15 나까니시 히로유끼 A pharmaceutical preparation containing a human growth hormone
US20070179096A1 (en) 1996-04-24 2007-08-02 Novo Nordisk A/S Pharmaceutical Formulation
KR20030038690A (en) 2000-08-07 2003-05-16 인헤일 테라퓨틱 시스템즈 인크. Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
AU2003303646B2 (en) 2002-12-31 2010-03-04 Altus Pharmaceuticals Inc. Human growth hormone crystals and methods for preparing them

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
DK204791D0 (en) * 1991-12-20 1991-12-20 Novo Nordisk As UNKNOWN PHARMACEUTICAL PREPARATION
DE10399015I1 (en) * 1991-12-20 2012-05-03 Novo Nordisk As Stabilized pharmaceutical formulation containing growth hormone and histidine

Also Published As

Publication number Publication date
JPH10511963A (en) 1998-11-17
KR19980701350A (en) 1998-05-15
AU4329496A (en) 1996-07-31
IL116741A0 (en) 1996-05-14
WO1996021459A1 (en) 1996-07-18
EP0804224A1 (en) 1997-11-05

Similar Documents

Publication Publication Date Title
ZA965368B (en) A pharmaceutical formulation
ZA96124B (en) A pharmaceutical formulation
GB9519363D0 (en) Pharmaceutical formulation
EG23826A (en) Pharmaceutical formulations
GB9523752D0 (en) Pharmaceutical formulations
GB9407386D0 (en) Pharmaceutical formulation
GB9402203D0 (en) Pharmaceutical formulation
IL112521A0 (en) Pharmaceutical formulation
EP0862431A4 (en) Pharmaceutical formulation
ZA958606B (en) A pharmaceutical formulation
EP0850057A4 (en) Pharmaceutical compounds
GB9405856D0 (en) Pharmaceutical formulation
GB9416599D0 (en) Pharmaceutical formulation
GB9523566D0 (en) Pharmaceutical formulation
ZA96526B (en) Novel pharmaceutical formulation
AU3949093A (en) A pharmaceutical formulation
ZA964372B (en) A pharmaceutical formulation
ZA965367B (en) A pharmaceutical formulation
AP9801196A0 (en) Pharmaceutical preparation
ZA96122B (en) A pharmaceutical formulation
SG47206A1 (en) Pharmaceutical compounds
ZA96392B (en) Pharmaceutical formulations
ZA96123B (en) A pharmaceutical formulation
GB9500978D0 (en) Pharmaceutical formulations
GB9502786D0 (en) Pharmaceutical formulation